Company Overview: Viatar CTC Solutions Inc.

Industry News

29 Mar

Viatar CTC Solutions Announces Filing of 10-K Annual Report

$4.2 Million Series B Financing Closed & Fully Funded LOWELL, MA–(Marketwired – Mar 28, 2016) – Viatar CTC Solutions, Inc. (OTCQB: VRTT), the cancer dialysis company, today filed its annual report on Form 10-K with the Securities and Exchange Commission. The filing no longer contains a “going concern” qualification from...

Read more

1 Mar

Viatar CTC Solutions Announces $4.2 Million Series B Financing

Reports 2015 Financial Results LOWELL, MA–(Marketwired – Mar 1, 2016) – Viatar CTC Solutions, Inc. (OTCQB: VRTT), the cancer dialysis company, today announced that it has entered into agreements with existing shareholders for the sale of $4.2 million of Series B Preferred Stock. This transaction post-deal values Viatar at approximately $60 million,...

Read more

30 Nov

Viatar CTC Solutions to Present at 8th Annual LD Micro Main Event Conference

LOWELL, MA–(Marketwired – Nov 30, 2015) –  Viatar CTC Solutions, Inc. (OTCQB: VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, today announced that Ilan Reich, Chairman and Chief Executive Officer, will present a corporate overview at the 8th Annual LD Micro Main Event being held on...

Read more

13 Nov

Viatar CTC Solutions Reports Third Quarter 2015 Highlights and Financial Results

LOWELL, MA–(Marketwired – Nov 13, 2015) – Viatar CTC Solutions, Inc. (OTCQB: VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, today announced highlights and financial results for the third quarter ended September 30, 2015. Generated $37,940 of revenue over the past four quarters from...

Read more

12 Nov

Viatar CTC Solutions Selected for Prestigious Cavendish Global Health Innovation Award

LOWELL, MA–(Marketwired – Nov 12, 2015) – Viatar CTC Solutions Inc. (OTCQB: VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, announced today that the Company was chosen to receive a Cavendish Global Health Innovation Award. Viatar CTC Solutions presented the Company’s technology during the recent Cavendish Global Health...

Read more

12 Aug

Viatar CTC Solutions Reports Second Quarter 2015 Highlights and Financial Results

LOWELL, MA–(Marketwired – Aug 12, 2015) – Viatar CTC Solutions, Inc. (OTCQB: VRTT), a medical technology company focused on the treatment of patients with metastatic cancer, today announced highlights and financial results for the second quarter ended June 30, 2015. Generated $32,955 of revenue over the past four quarters from...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address